Gyre Therapeutics to Acquire Cullgen in $300M All‑Stock Deal
Gyre Therapeutics announced an agreement to acquire Cullgen in an all‑stock transaction valued at approximately $300 million, making Cullgen a wholly‑owned subsidiary upon completion in Q2 2026. The combined biopharma company will integrate US and China capabilities across discovery, manufacturing and commercialization, targeting inflammatory diseases, cancer, pain and other therapeutic areas.
Quantum Health Acquires Virtual Care Provider CirrusMD
Healthcare navigation leader Quantum Health has completed the acquisition of on-demand virtual care provider CirrusMD, expanding its AI‑powered care platform. Financial terms were not disclosed, and the combined entity now serves over 20 million members with a chat‑first virtual care model.
Candid to Acquire Rallybio in Reverse Merger, Taking Company Public
Candid Therapeutics announced a reverse merger with Rallybio, creating a publicly traded company under the Candid name and ticker CDRX. The boards of both companies approved the transaction, which is expected to close in mid‑2026. The deal includes a $505 million...
Alveus Therapeutics Secures $37M Series A Extension Funding
Alveus Therapeutics Inc., a clinical‑stage biotech firm, closed a $37 million Series A extension round. The round was led by Jeito Capital and Novo Holdings, with participation from New Rhein Healthcare Investors, Andera Partners, Omega Funds, Sanofi Capital, Kurma Partners, Avego BioScience...
Eton Pharmaceuticals Acquires U.S. Commercialization Rights to Hemangeol From Pierre Fabre
Eton Pharmaceuticals announced it has in‑licensed the U.S. commercialization rights to Hemangeol®, the only FDA‑approved treatment for infantile hemangioma, from Pierre Fabre Medicament Sas. The acquisition, disclosed in early March 2026, will be financed with cash on hand and is...
Medimaps Group and Radiobotics Announce Strategic Merger to Expand AI-Driven Musculoskeletal Imaging Portfolio
Medimaps Group S.A., a Swiss AI-driven bone imaging leader, and Denmark’s Radiobotics ApS, an AI-powered musculoskeletal radiology firm, have signed a strategic merger agreement. The combined entity will offer an end‑to‑end AI musculoskeletal imaging platform across X‑ray and DXA, reaching...
RadNet’s DeepHealth Acquires French Radiology AI Leader Gleamer for €230M
U.S. outpatient imaging provider RadNet announced that its digital health subsidiary DeepHealth will acquire Paris‑based radiology AI company Gleamer in an all‑cash deal valued at up to €230 million ($269.05 million). The acquisition will integrate Gleamer’s AI triage and reporting tools into...
Forvis Mazars Acquires Healthcare Consultancy The Innova Group
Forvis Mazars US, a top‑10 accounting firm, announced the acquisition of The Innova Group, a healthcare consulting firm based in Austin, effective March 1, 2026. Financial terms were undisclosed, but the deal adds nine executives, about 50 professionals, and expands Forvis Mazars’...
Blue Arbor Technologies Raises $5M Series A Investment From Ottobock
Blue Arbor Technologies announced the first‑in‑human implant of its RESTORE External Sensing Unit and secured a $5 million investment from German prosthetics company Ottobock, the lead investor in its Series A round. The funding will support further development and clinical validation of...
Abram Scientific Closes $11.75M Series A Led by Octapharma
Abram Scientific, a Menlo Park‑based medical device firm specializing in coagulation diagnostics, announced the closing of an $11.75 million Series A round. The financing was led by Octapharma AG with participation from investors affiliated with the University of Colorado Anschutz. The capital will...
Cigna Acquires CarepathRx to Expand Hospital Pharmacy Services
Cigna announced the acquisition of CarepathRx, a private‑equity‑backed pharmacy that supplies prescription drugs to roughly 10% of U.S. hospitals. The deal expands Cigna’s vertical integration in the pharmaceutical supply chain, complementing its earlier purchase of Express Scripts.
Honest Health Secures $140M Funding Round Led by NewSpring Healthcare
Honest Health announced a $140 million fundraising round led by NewSpring Healthcare, with participation from K2 HealthVentures, Rubicon Founders, Oak HC/FT and other investors. The capital will be used to expand its value‑based care enablement platform across national health systems...
Asahi Kasei to Acquire German Biotech Aicuris for €780M
Japanese drugmaker Asahi Kasei announced it will acquire German biotech Aicuris for €780 million, gaining its antiviral therapy pritelivir targeting HSV. The deal expands Asahi Kasei's anti‑infectives portfolio and supports its goal of reaching JPY 300 billion in pharma sales by 2030.
Reframe Cancer Acquires Alvie Health to Expand Digital Cancer Prehabilitation
Reframe Cancer, the UK's leading specialist cancer navigation provider, has acquired Alvie Health, a digital cancer prehabilitation business founded by NHS surgeon Krishna Moorthy. The acquisition makes Reframe Cancer the largest cancer support business in the UK and will enable...
Natera Acquires Foresight Diagnostics to Boost Ultra‑Sensitive MRD Testing
Natera announced the acquisition of Foresight Diagnostics during its Q4 2025 earnings call on Feb. 26, 2026. The deal adds Foresight's phased‑variant technology to Natera's Signatera platform, enabling detection below one fragment per 10 million normal copies. Financial terms were not...
BrainCheck Raises $13M Series A Led by Next Coast Ventures
BrainCheck, a digital platform for cognitive assessment and care, announced a $13 million Series A financing round. The round was led by Next Coast Ventures with participation from S3 Ventures and UPMC Enterprises. The funding will support the company's growth and expansion...
Uplift Hospice Acquires Autumn View Hospice in Georgia
Uplift Hospice announced the acquisition of Georgia-based Autumn View Hospice for an undisclosed amount, expanding its daily census to over 650 patients across Arizona, Nevada, Texas and Georgia. The deal, facilitated by M&A advisory firm Agenda Health, will retain all...
GSK to Acquire 35Pharma for Under $1B
GlaxoSmithKline (GSK) announced the acquisition of privately held 35Pharma, a developer of a pulmonary arterial hypertension drug. The cash deal is valued at just under $1 billion, expanding GSK’s pipeline in respiratory and immunology.
Dovida Acquires A Place At Home to Enter US Market
Dovida, a home‑care provider operating in six international markets, announced the acquisition of Omaha‑based A Place At Home, marking its entry into the United States. The financial terms were not disclosed, and the A Place At Home brand and leadership...
Comanche County Memorial Hospital to Acquire Southwestern Medical Center
Comanche County Memorial Hospital announced an agreement to acquire Southwestern Medical Center, forming the Memorial Health System of Southwest Oklahoma. The deal, reported in early 2026, adds a 199‑bed rural hospital to the 265‑bed system, expanding its regional footprint.
Lockwood Group Acquires Total Health to Bolster Oncology Education Services
The Lockwood Group announced it has acquired Total Health, a leading provider of free oncology medical education. The deal expands Lockwood’s educational portfolio and strengthens its position in oncology communications and clinical insights. Financial terms were not disclosed.
Vuno Secures $7M Strategic Investment via Perpetual Convertible Bonds
South Korean medical AI firm Vuno announced a strategic investment of 10 billion won ($7 million) from the Compass Pathway NXVP New Technology Investment Fund No. 1. The funds will be issued as perpetual convertible bonds and used for operating capital to fuel...
Quadria Capital Completes $470M Take‑private of Apex Healthcare
Quadria Capital, an Asian healthcare‑focused private equity firm, has completed the acquisition of Apex Healthcare, taking it private in a deal valued at $470 million. The transaction, backed by co‑investors 65 Equity Partners, the Employees Provident Fund and Silk Road Fund,...
Coral Care Secures $13M Series A Funding Led by Haymaker Ventures
Coral Care, a platform delivering in‑home pediatric speech, occupational and physical therapy, announced a $13 million Series A round. The round was led by Haymaker Ventures with participation from FCA Ventures, Peterson Ventures and several other investors. The capital will fund national...
Kinderhook Industries to Acquire Enhabit in $1.1B All‑Cash Take‑Private Deal
Private equity firm Kinderhook Industries announced an agreement to acquire home‑health and hospice provider Enhabit Inc. in an all‑cash transaction valued at approximately $1.1 billion, taking the company private. The deal, expected to close in Q2 2026, will pay Enhabit shareholders $13.80...
Sunway Healthcare Targets RM3 Billion IPO, AIA and EPF Among Potential Cornerstone Investors
Sunway Healthcare, a leading private healthcare provider in Malaysia, announced plans for an IPO that could raise over RM3 billion, the largest in the country in nearly a decade. AIA and Malaysia’s Employees Provident Fund are among more than 20...
Gilead Sciences to Acquire Arcellx for up to $7.8B
Gilead Sciences announced it will acquire biotech Arcellx in a cash deal valued at up to $7.8 billion, paying $115 per share plus a contingent $5 per share based on future sales. The acquisition aims to strengthen Gilead's cancer drug pipeline,...
RevSpring Acquires TrustCommerce to Expand Integrated Healthcare Payment Gateway
RevSpring, backed by Frazier Healthcare Partners, announced the acquisition of TrustCommerce, a portfolio company of Waud Capital Partners, to build an end‑to‑end healthcare payment platform. The deal adds TrustCommerce’s enterprise gateway and EHR integrations to RevSpring’s patient engagement software, creating...
Voyageur Pharmaceuticals Secures Up to $2.35M Funding From Bayer
Voyageur Pharmaceuticals Ltd. announced a collaboration and milestone‑based funding agreement with Bayer, providing up to US$2.35 million to advance an iodine production project in Oklahoma. Funding will be released in three stages tied to feasibility‑study milestones, with Bayer receiving exclusivity to...
Heidi Acquires UK AI Healthcare Platform Automedica
Australian health‑tech scale‑up Heidi announced the acquisition of UK AI healthcare platform Automedica, expanding its AI product suite and UK regulatory presence. The terms were undisclosed. The deal follows Heidi’s $125 million fundraising round last year.
AlayaCare Secures $50M Growth Capital Facility From CIBC Innovation Banking
AlayaCare Inc., a Montreal‑based provider of home and community care software, secured a $50 million growth‑capital facility from CIBC Innovation Banking. The funding will fuel the company's expansion and support strategic mergers and acquisitions. The partnership builds on a relationship dating...
Axis Medical Secures Undisclosed Investment From Spur Ridge Capital
Denver-based Axis Medical, a distributor of spinal implant and orthobiologic technologies, received an undisclosed investment from Spur Ridge Capital. The funding will be used to accelerate growth through operational infrastructure, sales initiatives, and strategic expansion, including acquisitions, while the company...
BridgePoint Healthcare Sells D.C. Nursing Facility to Hill Valley Healthcare for $79M
BridgePoint Healthcare has sold its skilled nursing facility at 4601 Martin Luther King Jr. Ave. SW in Washington, D.C. to Hill Valley Healthcare for $79 million, according to deed records. Hill Valley financed the acquisition with a $53.7 million loan from Deutsche Bank,...
Candel Therapeutics Secures $100M Royalty Funding From RTW Investments
Candel Therapeutics announced a $100 million royalty financing agreement with RTW Investments to support the launch of its gene therapy Aglatimagene Besadenovec for localized prostate cancer. The deal grants RTW a capped, tiered royalty on U.S. net sales, contingent on...
Hims & Hers to Acquire Eucalyptus in $1.15B Deal
Direct-to-consumer virtual care company Hims & Hers announced it has signed an agreement to acquire international digital health platform Eucalyptus for up to $1.15 billion. The transaction includes $240 million cash at closing and the remainder in deferred and earn‑out payments, with...
Flinn Raises $20M to Develop AI-Driven Product Lifecycle Tools for Medtech and Pharma
Flinn announced a $20 million fundraising round to accelerate development of artificial intelligence tools for product lifecycle management in the medtech and pharmaceutical sectors. The capital will be used to build AI-driven solutions that streamline design, compliance, and market launch...
Gore Completes Acquisition of Conformal Medical
W. L. Gore & Associates, the materials‑science company, has finalized its acquisition of Conformal Medical, the developer of the CLAAS AcuFORM left atrial appendage occlusion system. Financial terms were not disclosed. Conformal Medical becomes a wholly‑owned subsidiary of Gore, continuing...
Charles River Laboratories Completes Acquisition of KF Cambodia
Charles River Laboratories International Inc announced the closing of its acquisition of KF Cambodia, a long‑time non‑human primate supplier, to strengthen its Discovery and Safety Assessment (DSA) supply chain and reduce costs. The deal, finalized in early 2026, is expected...
Sensei Biotherapeutics Acquires Faeth Therapeutics in Stock-for-Stock Deal, Raises $200M
Sensei Biotherapeutics announced the acquisition of Faeth Therapeutics in a stock-for-stock transaction, consolidating the two biotech firms. Concurrently, Sensei raised $200 million in a private placement to fund the development of PIKTOR, its multi-node PI3K/AKT/mTOR inhibitor. The acquisition price was...
Cencora to Acquire Covetrus in $3.5B Animal Health Merger
Cencora announced a $3.5 billion merger with Covetrus, creating a leading animal health company. The transaction, guided by three advisory firms, combines Cencora's distribution capabilities with Covetrus's veterinary services platform. The deal is expected to close later this year.
Synchrony Medical Raises $5M to Commercialize LibAirty Airway Clearance System
Synchrony Medical announced a $5 million fundraising round to fund the commercialization of its LibAirty airway clearance system. The capital will be used to scale production, pursue regulatory approvals, and expand market reach. The round marks a significant step in...
Tencent Acquires 35% Stake in Insighta From Prenetics for $70M
Prenetics Global Limited announced the sale of its 35% equity stake in Insighta to Tencent for $70 million in cash, as part of its strategic transformation to focus on its IM8 health brand. The deal, reported on February 18 2026, provides Prenetics with...
Rainfall Health Secures $15M Series A Funding Led by Two Bear Capital
Rainfall Health, an AI-driven compliance platform for hospitals, announced the closing of a $15 million Series A round led by Two Bear Capital, with participation from other investors. The funding will support the company’s expansion as it helps hospitals meet new CMS...
Korsana Raises $150M in Series A to Develop Next‑gen Alzheimer’s Antibody
Korsana, a biotech focused on Alzheimer’s disease, announced a $150 million Series A funding round to advance its next‑generation amyloid‑targeting antibody. The capital will fund clinical development and expansion of its pipeline. Investor identities were not disclosed.
Unnatural Products Secures $1.8B Cardio Pact with Novartis
Biotech firm Unnatural Products announced a $1.8 billion partnership with pharmaceutical giant Novartis to develop cardiovascular therapies. The agreement includes a corporate investment from Novartis, marking a significant funding boost for Unnatural Products.
Gilead to Acquire Genhouse in $1.5B+ Deal to Accelerate Synthetic Lethality
Gilead Sciences announced a deal to acquire Genhouse for over $1.5 billion, aiming to strengthen its synthetic lethality oncology pipeline. The acquisition brings Genhouse’s portfolio of synthetic lethality drug candidates and technology into Gilead’s pipeline, underscoring its commitment to precision oncology.
Eli Lilly Pays $100M for Rights to CSL’s Clazakizumab
Eli Lilly announced it will pay $100 million to CSL Limited for the rights to the IL‑6‑blocking antibody clazakizumab, with CSL retaining rights for cardiovascular prevention in end‑stage kidney disease patients. The deal includes an upfront payment and potential milestone and...
HotDoc Sold to Potentia in $250M-$300M Majority Stake Acquisition
Australian health‑tech platform HotDoc has been acquired by private‑equity firm Potentia, which led a bid for a majority stake. The deal, valued between $250 million and $300 million, also brings health‑tech investor Acclivis Group and long‑term backer Airtree into the ownership group....
Evaro Secures $25M Series A Funding Led by AlbionVC
Evaro, an NHS‑licensed digital health platform, raised $25 million in a Series A round led by AlbionVC with participation from Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC and BBI. The funding will accelerate its healthcare‑as‑a‑service model across consumer brands, healthcare organisations and employers.
VB Spine to Acquire Augmedics' Xvision Spine System
VB Spine announced it has signed a definitive agreement to acquire Augmedics' xvision Spine System, adding augmented reality navigation to its visualization portfolio. The transaction, pending regulatory approval, is expected to close in the coming weeks and follows VB Spine's...